The Interleukin-1 receptor antagonist is a direct target gene of PPARα in liver

Journal of Hepatology

Volumn 46, Issue 5, 2007, Pages 869-877

  Stienstra, Rinke ^a   Mandard, Stéphane ^a   Tan, Nguan Soon ^b   Wahli, Walter ^b   Trautwein, Christian ^c   Richardson, Terrilyn A ^d   Lichtenauer Kaligis, Elgin ^a   Kersten, Sander ^a   Müller, Michael ^a  

^a Nutrition   (Netherlands)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^d EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Inflammation; Interleukin 1 receptor antagonist; Liver; Microarray; PPAR

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; LIPOPOLYSACCHARIDE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; PIRINIXIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; FEMALE; GENE CONTROL; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; LIVER; MACROPHAGE; MICROARRAY ANALYSIS; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSACTIVATION; UPREGULATION;

ANIMALS; ANTICHOLESTEREMIC AGENTS; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION REGULATION; HEPATITIS; HEPATOCYTES; HUMANS; HYPOGLYCEMIC AGENTS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; LIVER; MALE; MICE; MICE, KNOCKOUT; PPAR ALPHA; PROMOTER REGIONS (GENETICS); PYRIMIDINES; RECEPTORS, INTERLEUKIN-1 TYPE I; RNA, MESSENGER; THIAZOLIDINEDIONES; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 34047187449     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.11.019     Document Type: Article

References (27)

1. Robinson-Rechavi M., Escriva Garcia H., and Laudet V. The nuclear receptor superfamily. J Cell Sci 116 (2003) 585-586
2. Desvergne B., and Wahli W. Peroxisome proliferator-activated receptors: nuclear control of metabolism. Endocr Rev 20 (1999) 649-688
3. Mandard S., Müller M., and Kersten S. Peroxisome proliferator-activated receptor alpha target genes. Cell Mol Life Sci 61 (2004) 393-416
4. Kersten S., Mandard S., Escher P., Gonzalez F.J., Tafuri S., Desvergne B., et al. The peroxisome proliferator-activated receptor alpha regulates amino acid metabolism. FASEB J 15 (2001) 1971-1978
5. Devchand P.R., Keller H., Peters J.M., Vazquez M., Gonzalez F.J., and Wahli W. The PPARalpha-leukotriene B4 pathway to inflammation control. Nature 384 (1996) 39-43
6. Delerive P., Fruchart J.C., and Staels B. Peroxisome proliferator-activated receptors in inflammation control. J Endocrinol 169 (2001) 453-459
7. Lo Verme J., Fu J., Astarita G., La Rana G., Russo R., Calignano A., et al. The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol Pharmacol 67 (2005) 15-19
8. Delerive P., De Bosscher K., Besnard S., Vanden Berghe W., Peters J.M., Gonzalez F.J., et al. Peroxisome proliferator-activated receptor alpha negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-kappaB and AP-1. J Biol Chem 274 (1999) 32048-32054
9. Delerive P., De Bosscher K., Vanden Berghe W., Fruchart J.C., Haegeman G., and Staels B. DNA binding-independent induction of IkappaBalpha gene transcription by PPARalpha. Mol Endocrinol 16 (2002) 1029-1039
10. Dubuquoy L., Dharancy S., Nutten S., Pettersson S., Auwerx J., and Desreumaux P. Role of peroxisome proliferator-activated receptor gamma and retinoid X receptor heterodimer in hepatogastroenterological diseases. Lancet 360 (2002) 1410-1418
11. Welch J.S., Ricote M., Akiyama T.E., Gonzalez F.J., and Glass C.K. PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages. Proc Natl Acad Sci USA 100 (2003) 6712-6717
12. Lee C.H., Chawla A., Urbiztondo N., Liao D., Boisvert W.A., Evans R.M., et al. Transcriptional repression of atherogenic inflammation: modulation by PPARdelta. Science 302 (2003) 453-457
13. Kuipers F., Jong M.C., Lin Y., Eck M., Havinga R., Bloks V., et al. Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E-deficient mouse hepatocytes. J Clin Invest 100 (1997) 2915-2922
14. Di Poi N., Tan N.S., Michalik L., Wahli W., and Desvergne B. Antiapoptotic role of PPARbeta in keratinocytes via transcriptional control of the Akt1 signaling pathway. Mol Cell 10 (2002) 721-733
15. Lennard A.C. Interleukin-1 receptor antagonist. Crit Rev Immunol 15 (1995) 77-105
16. Butcher C., Steinkasserer A., Tejura S., and Lennard A.C. Comparison of two promoters controlling expression of secreted or intracellular IL-1 receptor antagonist. J Immunol 153 (1994) 701-711
17. Gabay C., Porter B., Guenette D., Billir B., and Arend W.P. Interleukin-4 (IL-4) and IL-13 enhance the effect of IL-1beta on production of IL-1 receptor antagonist by human primary hepatocytes and hepatoma HepG2 cells: differential effect on C-reactive protein production. Blood 93 (1999) 1299-1307
18. Gabay C., Smith M.F., Eidlen D., and Arend W.P. Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein. J Clin Invest 99 (1997) 2930-2940
19. Orfila C., Lepert J.C., Alric L., Carrera G., Beraud M., and Pipy B. Immunohistochemical distribution of activated nuclear factor kappaB and peroxisome proliferator-activated receptors in carbon tetrachloride-induced chronic liver injury in rats. Histochem Cell Biol 123 (2005) 585-593
20. Kleemann R., Gervois P.P., Verschuren L., Staels B., Princen H.M., and Kooistra T. Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFkappa B-C/EBP-beta complex formation. Blood 101 (2003) 545-551
21. Gabay C., Gigley J., Sipe J., Arend W.P., and Fantuzzi G. Production of IL-1 receptor antagonist by hepatocytes is regulated as an acute-phase protein in vivo. Eur J Immunol 31 (2001) 490-499
22. Gabay C., Porter B., Fantuzzi G., and Arend W.P. Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo. J Immunol 159 (1997) 5905-5913
23. Gregory S.H., and Wing E.J. Neutrophil-Kupffer cell interaction: a critical component of host defenses to systemic bacterial infections. J Leukoc Biol 72 (2002) 239-248
24. Gervois P., Kleemann R., Pilon A., Percevault F., Koenig W., Staels B., et al. Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome proliferator-activated receptor-alpha activator fenofibrate. J Biol Chem 279 (2004) 16154-16160
25. Gervois P., Vu-Dac N., Kleemann R., Kockx M., Dubois G., Laine B., et al. Negative regulation of human fibrinogen gene expression by peroxisome proliferator-activated receptor alpha agonists via inhibition of CCAAT box/enhancer-binding protein beta. J Biol Chem 276 (2001) 33471-33477
26. Chikano S., Sawada K., Shimoyama T., Kashiwamura S.I., Sugihara A., Sekikawa K., et al. IL-18 and IL-12 induce intestinal inflammation and fatty liver in mice in an IFN-gamma dependent manner. Gut 47 (2000) 779-786
27. Desiderio S., and Yoo J.Y. A genome-wide analysis of the acute-phase response and its regulation by Stat3beta. Ann N Y Acad Sci 987 (2003) 280-284